IVI To Speed Development Of MERS Vaccines
This article was originally published in PharmAsia News
In a move that will speed up work in the area, the International Vaccine Institute (IVI) is to launch a project for the research and development of vaccines for Middle East Respiratory Syndrome (MERS) with financial support from South Korea’s Samsung Medical Center. The institute is in the process of selecting collaborators that have data suggesting protection in animal models.
Register for our free email digests: